Top 5 Cosmetic Plastic Minimally Invasive Procedures in 2009

Cosmetic minimally-invasive procedures increased 1 percent, to nearly 11 million procedures in 2009 according to statistics released by the American Society of Plastic Surgeons. Minimally-invasive procedures are up 99 percent since 2000. The top five minimally-invasive procedures in 2009 were:

* Botulinum toxin type A (4.8 million)
* Soft tissue fillers (1.7 million)
* Chemical peel (1.1 million)
* Microdermabrasion (910,000)
* Laser hair removal (893,000)

“Skin is in,” said Dr. McGuire. “Chemical peels and soft tissue fillers like hyaluronic acid are up 9 percent, microdermabrasion is up 8 percent – these are the procedures that patients are opting for despite the economy.”

“It would seem, as innovations in cosmetic minimally-invasive procedures increase, surgery will continue to decrease,” added Dr. McGuire. “However, as the economy rebounds, more patients and Boomers will continue to seek surgical body contouring procedures (liposuction, tummy tuck), eyelid surgery and breast augmentations. In fact, breast augmentations are up 36 percent since 2000. Silicone implants are now used in 50 percent of all breast augmentations.”

Top 5 Cosmetic Plastic Surgery Procedures in 2009

Although it’s been a sluggish year for plastic surgery due to the economy the long-term outlook is more encouraging. According to statistics released by the American Society of Plastic Surgeons (ASPS), 12.5 million cosmetic plastic surgery procedures were performed in the United States in 2009.

Cosmetic surgical procedures decreased 9 percent, with more than 1.5 million procedures in 2009. Surgical procedures are down 20 percent since 2000. The top five surgical procedures in 2009 were:

* Breast augmentation (289,000)
* Nose reshaping (256,000)
* Eyelid surgery (203,000)
* Liposuction (198,000)
* Tummy tuck (115,000)

Before and after a breast augmentation surgery

Read the rest of this entry »

FDA Approves First Sclerosant to Treat Small Varicose Veins in 60 Years

Washington – Merz Aesthetics  makes its debut at the prestigious American Society of Aesthetic Plastic Surgeons (ASAPS) annual meeting with the announcement of the U.S. Food and Drug Administration’s (FDA) recent approval of Asclera™ (polidocanol) Injection, a sclerotherapy treatment for uncompplicated spider and reticular veins.

“Spider and reticular veins are a common, often embarrassing condition that can be treated safely and effectively,” said Robert A. Weiss, M.D., director of the Maryland Laser, Skin, and Vein Institute and Associate Professor of Dermatology at Johns Hopkins University School of Medicine in Baltimore, MD. “Asclera™ is a minimally-invasive option for patients who are unhappy with the appearance of their legs.”

The FDA approved Asclera™ (polidocanol) Injection on March 30, 2010 to sclerose uncomplicated spider veins (varicose veins less than or equal to 1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the lower extremity, making it the first sclerosant to be approved in over 60 years.  Once injected, Asclera™ acts by damaging the cell lining of blood vessels, causing them to close and eventually be replaced by other types of tissue. Asclera™ is safe and effective when used as directed. Commonly observed local adverse events included injection site hematoma, irritation, and discoloration. Asclera™ has not been studied in varicose veins more than 3 mm in diameter.

“We are very excited about the approval of this treatment, expanding our aesthetics portfolio with products that really matter to patients,” said Dennis Condon, President of BioForm Medical, Inc., a Merz Aesthetics company. “Merz Aesthetics is committed to bringing forward true innovation to solve real problems that impact the lives of aesthetics users, and this takes us in the right direction.”

During the meeting, the company will also unveil the first phase of a unique national consumer survey of women’s experiences and perceptions of minimally-invasive cosmetic procedures. The results shed some light on the underlying motivations behind these women’s cosmetic procedure choices.

Obese women who have bariatric surgery before getting pregnant are at significantly lower risk for developing dangerous hypertensive disorders during pregnancy than those who don’t, according to a study of medical insurance records by Johns Hopkins experts.

Hypertensive disorders in pregnancy — which include gestational hypertension, preeclampsia and eclampsia — complicate an estimated 7 percent of pregnancies in the United States. Researchers say they are much more common in obese women, who make up a third of women of childbearing age.

“We have long known that women who have these blood pressure disorders are not only at an increased risk for pregnancy complications in themselves and their babies, but also for chronic diseases in the future,” says Wendy L. Bennett, M.D., M.P.H., assistant professor of medicine at the Johns Hopkins University School of Medicine and a study leader. “Can we prevent the development of these disorders in pregnancy with bariatric surgery? These findings suggest the answer may be ‘yes.’”

Results of the research are published online in the British Medical Journal.

Before and after bariatric surgery

Read the rest of this entry »

- Baby boomers keep cosmetic procedures on the rise

- Facelifts, eyelid lifts among anti-aging surgeries up in 2009

Chicago – The baby boomer generation may be well into their 50s and 60s, but that doesn’t mean they’re ready to concede their looks just yet. In fact, many “boomers” are determined to maintain their once-youthful appearance.

According to a recent survey by the American Academy of Cosmetic Surgery, anti-aging procedures such as facelifts and blepharoplasty (eyelid lifts) are on the rise. So are botox and fillers. The bottom line is that baby boomers are aging but they don’t want their looks to do the same.

Before and after blepharoplasty

“The baby boomers are getting older but they still feel young and they want to look that way too,” said AACS President Mark Berman, MD. “With anti-aging procedures, people tend to feel much better about themselves afterward.”

Facelifts rose 44 percent from 2008 to 2009 in procedures by AACS members, totaling 34,455 in ’09. Blepharoplasty procedures went up 42 percent, from 42,602 to 60,507. Similarly, non-invasive anti-aging procedures such as Botox (up 157 percent) and fillers (up 245 percent) rose exponentially.

In procedures performed by AACS members, the average age of facelift patients is 54.1 years. The average age for blepharoplasty is 52.3 years. In addition, the average age of patients receiving Botox is 46.6 and fillers is 46.8.

“I think this might come as a surprise to the public when they see just how many baby boomers are trying to slow down the aging process,” Berman said. “As a surgeon, these numbers aren’t surprising because we see older patients all the time.”

Source: American Academy of Cosmetic Surgery

For more information about plastic surgery procedures don’t hesitate to contact Sublimis – Medical Tourism.

Statement regarding PIP implants warning from the MHRA

London – As the discovery that the substance inside a cut-price breast implant is not what had been tested initially to make its use legal, the British Association of Aesthetic Plastic Surgeons, the not-for-profit organisation established for the advancement of education and practice of Aesthetic Plastic Surgery for public benefit, warns the public that choosing a provider solely on price can backfire.

As the French company behind PIP implants goes into liquidation, consultant plastic surgeon and BAAPS former President Douglas McGeorge says; “There have been questions about the safety and efficacy of these implants in the past – but as they were a ‘cheap’ option they may have proven popular with the commercial chains. Although it is unlikely that anyone’s health is in immediate danger, this must remind everyone that price should never be the sole consideration when choosing a cosmetic surgery provider.”

According to Nigel Mercer, consultant plastic surgeon and BAAPS President; “Concerned patients should contact their surgeon to find out what implants they have. Only PIP implants are involved and as yet there is no evidence that the gel they contained is harmful and we understand that it will not leak into the body. ”

The Medicines and Healthcare products Regulatory Agency (MHRA) is in close discussions with the French Regulatory Authority for Devices (AFSSAPS) as the product has now been taken off the market, and will be indicating if follow-up of patients is required.

Belief that intentional weight loss is harmful to seniors is unfounded

Winston-Salem, NC – A new study by researchers at Wake Forest University Baptist Medical Center is the first to refute the widely held belief that intentional weight loss in older adults leads to increased risk of death.

In fact, the research shows that seniors who intentionally exercised and/or modified their diets to lose weight were half as likely to die within eight years of follow-up as their peers who did not work toward weight loss, said M. Kyla Shea, Ph.D., first author on the study and a research associate in the Department of Internal Medicine, Section on Gerontology and Geriatric Medicine.

“It was an unusually strong and surprising finding,” Shea said. “Our data suggest that people should not be concerned about trying or recommending weight loss to address obesity-related health problems in older adults.”

The study, funded by the National Institute on Aging, is currently available online and is schedule to appear in a future print issue of the Journal of Gerontology: Medical Sciences.

Prior to this study, research that has looked at the association between mortality and weight loss has not factored in the many different potential causes of the weight loss. So, using a more rigorous randomized trial approach, Shea and colleagues sought to prove or disprove the idea that older individuals who actively tried to lose weight increased their risk of death.

Read the rest of this entry »